Top CTO Executive Search Firm in Mumbai for Pharma & Biotech — 2026

Mumbai is the corporate headquarters of much of India's pharmaceuticals industry — global Indian pharma majors and specialty businesses run from the city — and around them a digital-R&D, discovery-AI and pharma-data-product scene has taken root. The pharma-and-biotech CTO here is a product-and-platform engineering builder, sharply distinct from the validated-systems IT role that keeps GxP infrastructure compliant: the leader owns the discovery-AI and digital-R&D platforms, the commercial-and-data products that reshape how pharma sells and engages, the computational and techbio platforms, and the data engineering that makes scientific and commercial data usable. The CIO keeps the regulated estate running; this CTO builds the science and commercial products on top of it.

The scarcity is the engineering leader who can build scientific-computing, discovery-AI and pharma-data products — pairing deep software and ML engineering with fluency in the science or the commercial domain; the failure mode is the software leader who cannot engage with the science, or the domain expert who cannot build a modern software-product organisation. Pay is set by the product reality: venture-backed techbio and pharma-tech are equity-led with ESOP, while pharma-major digital settings blend a strong base with performance pay and long-term incentives — the brief sets which. The stakeholder map runs from founders or the digital/R&D chief through scientific and commercial leadership to investors. References reach to engineering reports and scientists, because whether a leader can build products the science and the business trust is answered only by those who have watched the platforms deliver.